Autori: Conte Pier Franco
| Naslov | Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer (Article) |
| Autori | Conte Pier Franco ... Stamatovic Ljiljana ... (broj koautora 21) |
| Info | CANCER, (2020), vol. 126 br. 13, str. 3132-3139 |
| Projekat | Roche HoldingGenentech |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
